Aubrey de Grey (Photo by Sergei Bobylev\TASS via Getty Images)
August 13, 2021 10:24 AM EDT
People

As Aubrey de Grey in­ves­ti­ga­tion swirled, SENS CEO left foun­da­tion in Ju­ly — re­port

Max Gelman

Senior Editor

A new de­vel­op­ment in the sex­u­al ha­rass­ment al­le­ga­tions against promi­nent an­ti-ag­ing re­searcher Aubrey de Grey is shed­ding light on some of the rea­sons his two …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times